Pyruvate dehydrogenase deficiency
1,125views
Pyruvate dehydrogenase deficiency
SFM Block
SFM Block
Homocystinuria
Alkaptonuria
Phenylketonuria (NORD)
Cystinuria (NORD)
Maple syrup urine disease
Lysosomal storage disorders: Pathology review
Glucose-6-phosphate dehydrogenase (G6PD) deficiency
Pyruvate dehydrogenase deficiency
Fatty acid oxidation
Fatty acid synthesis
Physiological changes during exercise
Ketone body metabolism
Cholesterol metabolism
Dyslipidemias: Pathology review
Vitamin B12 deficiency
Folate (Vitamin B9) deficiency
Pharmacokinetics: Drug metabolism
Acetaminophen (Paracetamol)
Ectoderm
Mesoderm
Endoderm
Amyloidosis
T-cell development
B-cell development
MHC class I and MHC class II molecules
T-cell activation
B-cell activation and differentiation
Cell-mediated immunity of CD4 cells
Cell-mediated immunity of natural killer and CD8 cells
Antibody classes
Somatic hypermutation and affinity maturation
VDJ rearrangement
Assessments
Flashcards
0 / 9 complete
High Yield Notes
4 pages



Flashcards
Pyruvate dehydrogenase deficiency
0 of 9 complete
Summary
Pyruvate dehydrogenase deficiency (PDD) is an inherited disorder that affects the breakdown of carbohydrates, proteins, and fats. It is caused by a deficiency of the enzyme pyruvate dehydrogenase (PDH), which is responsible for converting pyruvate (a product of carbohydrate metabolism) into acetyl-coenzyme A, which then enters the Krebs cycle and produces energy. PDD can lead to a range of symptoms including muscle weakness, fatigue, seizures, developmental delays, and poor growth. Treatment of PDD involves dietary modifications, dietary supplements, and medications such as thiamine.